IC PHARMA
0505.707.124 · rovalta.com · 06/11/2026
ACTIVE
IC PHARMA
Financial year 2025 · Closed on 30/06/2025
Net result128,6 k €-16,3 %over 1 year
Gross margin434,6 k €+3,5 %over 1 year
Equity500,3 k €+1,8 %over 1 year
Workforce2,9 ETP+3,6 %over 1 year
Overview
Identity
Source · BCE/KBOIC PHARMA is a Private limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Tubize. It employs on average 2,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0505.707.124
- Incorporation
- 26/11/2014
- Legal form
- Private limited company
- Registered office
- Rue François Englert 10
1480 Tubize · WallonieSee on map - Contributed capital
- 98 600,00 €
- Latest accounts
- 30/06/2025
- Average workforce
- 2,9 ETP
Joint committees (1)
- 200
Signals
ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 434,6 k € | +3.5% | 419,9 k € | -3.9% | 437 k € | -16.5% | 523,1 k € | -9.5% | 578,3 k € |
| EBITDA | 187,3 k € | -15.2% | 221 k € | -3.0% | 227,8 k € | -15.7% | 270,1 k € | -30.5% | 388,9 k € |
| Operating result | 168,3 k € | -19.5% | 209,2 k € | -3.9% | 217,7 k € | -15.8% | 258,5 k € | -31.9% | 379,5 k € |
| Net result | 128,6 k € | -16.3% | 153,7 k € | -5.1% | 161,9 k € | -20.7% | 204,2 k € | -41.7% | 350,1 k € |
| Balance sheet | |||||||||
| Equity | 500,3 k € | +1.8% | 491,6 k € | +7.4% | 458 k € | +10.1% | 416 k € | +25.4% | 331,8 k € |
| Total assets | 3,2 M € | +0.9% | 3,1 M € | +25.9% | 2,5 M € | +3.3% | 2,4 M € | +10.9% | 2,2 M € |
| Cash | 267,3 k € | -16.2% | 319,1 k € | +333% | 73,7 k € | -6.5% | 78,8 k € | -7.8% | 85,6 k € |
| Debts | 2,7 M € | +0.7% | 2,6 M € | +31.1% | 2 M € | +1.9% | 2 M € | +8.4% | 1,8 M € |
| Other | |||||||||
| Workforce | 2,9 ETP | +3.6% | 2,8 ETP | -15.2% | 3,3 ETP | -13.2% | 3,8 ETP | +2.7% | 3,7 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 10/10/2019Manager26/11/2014 → 2019 accountsended | |||
Tangie Le Gall | Directorsince 10/10/2019 |
Other companies at this address
Rue François Englert 10 1480 Tubize| Company | CBE no. |
|---|---|
CiGuPhar● Active | 0768.329.971 |
COSMEX● Active | 0765.522.317 |
IC Store● Active | 1032.517.092 |
INTERCONCEPT● Active | 0543.451.903 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/01/2026 | 28/02/2025 | 29/01/2024 | 13/02/2023 | 30/12/2021 | 28/02/2021 |
| General meeting | 20/12/2025 | 21/12/2024 | 16/12/2023 | 17/12/2022 | 18/12/2021 | 18/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 20/12/2025 | 28/01/2026 | French | |
| Abridged model | 30/06/2024 | 21/12/2024 | 28/02/2025 | French | |
| Abridged model | 30/06/2023 | 16/12/2023 | 29/01/2024 | French | |
| Abridged model | 30/06/2022 | 17/12/2022 | 13/02/2023 | French | |
| Abridged model | 30/06/2021 | 18/12/2021 | 30/12/2021 | French | |
| Abridged model | 30/06/2020 | 18/12/2020 | 28/02/2021 | French | |
| Abridged model | 30/06/2019 | 21/12/2019 | 30/01/2020 | French | |
| Abridged model | 30/06/2018 | 17/11/2018 | 25/01/2019 | French | |
| Abridged model | 30/06/2017 | 18/11/2017 | 28/12/2017 | French | |
| Abridged model | 30/06/2016 | 20/12/2016 | 21/12/2016 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 10/10/2019Manager26/11/2014 → 2019 accountsended | |||
Tangie Le Gall | Directorsince 10/10/2019 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office18/06/2024MAATSCHAPPELIJKE ZETEL
- Registered office22/09/2021SIEGE SOCIAL
- Mandates15/10/2019STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Registered office16/08/2019SIEGE SOCIAL
- Other25/10/2017ADOPTION DES NOUVEAUX STATUTS EN LANGUE FRANCAISE
- Registered office23/10/2017ZETELVERPLAATSING — AANNEMING VAN NIEUWE STATUTEN IN DE
- Other28/09/2015STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office27/08/2015SIEGE SOCIAL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings10 filings
Mandates
INTERCONCEPT
Tangie Le Gall
2014201520162017201820192020202120222023202420252026
IC PHARMA
Rue François Englert 10, 1480 TubizeRue du Congrès 35, 1000 Brussels
DirectorManager
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue François Englert 10, 1480 TubizeCurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00015539 |
| Rue du Congrès 35, 1000 Brussels | accounts 2022 → 2023 | Accounts 2023 · 2024-00009032 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| IC PHARMACurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00015539 |
Events
- 2025Annual accounts 2025128,6 k €↓
- 2024Annual accounts 2024153,7 k €↓
- 2023Annual accounts 2023161,9 k €↓
- 2022Annual accounts 2022204,2 k €↓
- 2021Annual accounts 2021350,1 k €↑
- 2020Annual accounts 2020-223,7 k €↓
- 2019Annual accounts 2019264,7 k €↑
- 2018Annual accounts 2018-203,4 k €↓
- 2017Annual accounts 201724,5 k €↓
- 2016Annual accounts 2016221 k €
- 26/11/2014IncorporationPrivate limited company